Clinical trial · Interventional
Integrated Smartphone Technology to Alleviate Malignant Pain (I-STAMP) Testing
Integrated Smartphone Technology to Alleviate Malignant Pain (I-STAMP): Development, Usability, and Acceptability Testing
NCT06117709CI-TRIAL-00118303not yet recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of the study is to evaluate if the smartphone app, I-STAMP (Integrated Smartphone Technology to Alleviate Malignant Pain), helps participants with cancer pain manage symptoms and keep track of medications.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Advanced Cancer | Malignant Neoplasm | CURATED_BROADER | 0.78 |
| Pain | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| I-STAMP | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- I-STAMP Testing
- description
- Study procedures will be conducted as follows: Activities 1-3: Data Collection for application development Activity 4: To be added with future amendment
- interventionNames
- Behavioral: I-STAMP
Primary outcomes (2)
- measure
- Usability
- timeFrame
- 2 weeks
- description
- Patients will complete a validated 10-item system usability scale (SUS) with total scores ranging from 0-100, where a score of 100 being the best possible usability score.
- measure
- E-scale Acceptability
- timeFrame
- 2 weeks
- description
- Patients will rate overall acceptability of the application using a modified acceptability e-scale. This 6-item measure asks patients to rate the app on ease of use, understandability, enjoyment, helpfulness, time spent, and overall satisfaction, on a 1 to 5 Likert scale. Items are summed to for a total score, ranging from 6 to 30 with 30 being the highest acceptability score.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 21 Years
Show eligibility criteria text
Inclusion Criteria for Participants (Activities 1a, 2a, 3a): * Age ≥ 21 years * Current or previous diagnosis of advanced cancer * Current or previous experience with cancer pain Exclusion Criteria for Participants (Activities 1a, 2a, 3a): * Inability to understand, speak, or read English * Any condition that would impede the patient's ability to complete study procedures such as visual impairment or significant cognitive impairment as determined by the participant's treating provider.
References
Publications (0)
Data not yet available
No reference posted for this study.